Najat Khan, PhD, unpacks realistic timelines for AI-based drugs to make clinical impact and her priorities for Recursion as incoming CEO.

As of the November 25, 2025 data cutoff in the open-label Phase 2 portion of TUPELO, treatment with REC-4881 (4 mg QD) ...

Recursion Pharmaceuticals (RXRX) is drawing renewed attention after the appointment of Najat Khan as CEO and news of a narrowing net loss, both viewed as signals of improving execution. Investors also ...

C compiler, LustreC, into a generator of both executable code and associated specification. Model-based design tools are ...

Crack the code of Instagram’s 2026 algorithm with insider secrets and proven IG engagement tips to maximize your content’s reach and visibility. Pixabay, ALUREAN Instagram's algorithm has always been ...

A nostalgic hit built out of vintage pop-culture references captured the “If you liked that, you’ll like this” spirit of Netflix. In the summer of 2016, streaming TV was still figuring itself out.

Researchers at Universidad Carlos III de Madrid (UC3M) have developed a set of innovative methods and algorithms that improve the performance and precision of vehicle design through topological ...